| Financial Year |
March 31 2023 |
| Monetary Funds |
521,713,999.22 |
| Held-for-trading Financial Assets |
63,676,925.21 |
| Notes Receivable |
1,739,338.35 |
| Accounts Receivable |
319,233,835.25 |
| Advances to Suppliers |
43,738,764.48 |
| Other Receivables |
6,878,673.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
450,395,204.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
37,581,077.41 |
| Total Current Assets |
1,490,157,096.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
16,316,259.06 |
| Investment Properties |
34,915,708.49 |
| Fixed Assetes |
717,205,920.04 |
| Under-construction Projects |
62,545,237.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
125,309,017.60 |
| R&D expenses |
773,445.11 |
| Goodwill |
19,138,913.71 |
| Long-Term Deferred and Prepaid Expenses |
3,282,982.80 |
| Deferred Income Tax Assets |
12,480,520.34 |
| Other Non-Current Assets |
27,310,553.24 |
| Sub-Total of Non-Current Assets |
1,096,836,790.04 |
| Total Assets |
2,586,993,886.18 |
| Short-Term Loans |
39,798,680.00 |
| Trading Financial liabilities |
512,186.66 |
| Notes Payable |
178,148,178.41 |
| Accounts Payable |
324,119,947.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,463,064.19 |
| Taxes Payable |
11,502,397.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,578,850.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
87,125,461.51 |
| Other Current Liabilities |
12,652,357.88 |
| Sub-Total of Current Liabilities |
722,796,366.85 |
| Long-term Loans |
100,964,937.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,024,143.10 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,445,771.49 |
| Deferred Income Tax Liabilities |
9,490,054.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
224,704,808.88 |
| Total Liabilities |
947,501,175.73 |
| Paid-In Capital(Or Share Stock) |
229,532,531.00 |
| Capital Surplus |
579,161,080.86 |
| Surplus Reserve |
113,909,545.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
700,691,770.78 |
| Minority Stockholder's Interest |
29,989,268.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,609,503,441.73 |
| Owner's Equity（Stockholder's Equity） |
1,639,492,710.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,586,993,886.18 |
